title: New epidemiology of Staphylococcus aureus infections in the Middle East.
abstract: Staphylococcus aureus is a bacterial pathogen that is distributed worldwide and represents an increasing problem, both in hospitals and in the community. Global transmission of methicillin-resistant S. aureus (MRSA) has been the subject of many studies. Determining the incidence of colonization with community-acquired MRSA in hospitalized patients and outpatients has been the aim of several studies conducted in the Middle East (western Asia). The local epidemiology within countries in this region is changing, owing to the introduction of new strains with the intercontinental exchange of several clones. Sequence type 80-MRSA-IV is one common clone detected in different countries within the region showing country-based differences, and hence more likely to form clonal lineages. MRSA is endemic in this region, and the burden and the difficulty in detecting imported strains are increasing. This is also increasing the risk of domestic and global transmission. To counter the threat associated with the high incidence of MRSA carriage and infections, systematic surveillance of both hospital and community isolates is required, along with appropriate measures designed to limit their spread. Additionally, antibiotic stewardship is needed to contain the further development of the observed resistance and to help in preserving antibiotics as precious therapeutic resources. It is critical for countries in this region to establish both national and international initiatives to develop better measurements designed to limit and control the spread of infections. Finally, more sequence-based studies are needed to better understand the pathogenicity and epidemiology of these important pathogens.
authors.affiliation: Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, Byblos, Lebanon.
authors.forename: S
authors.initials: S
authors.lastname: Tokajian
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State / Q000453:epidemiology / Q000382:microbiology; D003140:Communicable Disease Control / Q000458:organization & administration; D017714:Community-Acquired Infections / Q000453:epidemiology* / Q000382:microbiology; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D004363:Drug Utilization / Q000592:standards; D062665:Epidemiological Monitoring; D006801:Humans; D007391:International Cooperation; D016106:Methicillin Resistance; D008877:Middle East / Q000453:epidemiology; D017720:Molecular Epidemiology; D015995:Prevalence; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000145:classification / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents
keywords: Epidemiology; Middle East; ST80-MRSA-IV; methicillin-resistant S. aureus; resistance